Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss (Unaudited)

v2.4.0.6
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Consolidated Statements of Loss and Comprehensive Loss [Abstract]    
COLLABORATION REVENUE [note 3] $ 1,316 $ 1,199
EXPENSES    
Research and development 5,082 4,853
General and administrative 1,737 1,571
Total expenses 6,819 6,424
LOSS FROM OPERATIONS 5,503 5,225
OTHER INCOME (EXPENSE)    
Interest income 50 56
Other 23 (4)
(Loss) gain on warrants [notes 4 and 5] (1,430) 2,128
Total other (expense) income (1,357) 2,180
Loss for the period before income taxes 6,860 3,045
Income taxes      
Net loss 6,860 3,045
OTHER COMPREHENSIVE INCOME (LOSS)    
Unrealized gain on cash equivalents and marketable securities   70
Unrealized loss on cash equivalents and marketable securities (5) (48)
Total other comprehensive (loss) income (5) 22
Total comprehensive loss $ 6,865 $ 3,023
Basic and diluted loss per common share [note 5(c)] $ 0.67 $ 0.31
Weighted average number of common shares [note 5(c)] 10,235,237 9,713,413